Jessica Wallen
Family · Scottsville, KYNPI 1427670827
Payments from drug & device makers
Across 142 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$736
- Novo Nordisk$256
- Axsome Therapeutics, Inc.$187
- Phathom Pharmaceuticals, Inc.$180
- Lilly USA, LLC$154
- Novartis$98
- plus $827 from 22 others
What the payments were for
- Food & beverage$2,439100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $736 |
| Novo Nordisk | 15 | $256 |
| Axsome Therapeutics, Inc. | 10 | $187 |
| Phathom Pharmaceuticals, Inc. | 6 | $180 |
| Lilly USA, LLC | 10 | $154 |
| Novartis | 6 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Dexcom, Inc. | 4 | $72 |
| Pfizer | 4 | $67 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Amgen | 4 | $62 |
| Boehringer Ingelheim | 4 | $59 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $51 |
| Lundbeck LLC | 2 | $45 |
| Insulet Corporation | 2 | $34 |
| Bayer | 2 | $33 |
| Astellas Pharma US Inc | 2 | $31 |
| Exact Sciences | 2 | $30 |
| Corcept Therapeutics | 2 | $29 |
| GSK | 2 | $28 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Bioxcel Therapeutics, Inc. | 1 | $21 |
| Shield Therapeutics Inc | 1 | $19 |
| Tonix Medicines, Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $16 |
| Medtronic | 1 | $15 |
| Evoke Pharma, Inc. | 1 | $14 |
| Cepheid | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,439 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $18,785 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $12,046 |
| Ventolin HfaAlbuterol Sulfate | 19 | $1,046 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $772 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 78 | $554 |
| Levothyroxine Sodium | 57 | $447 |
| Pantoprazole Sodium | 31 | $426 |
| Azithromycin | 48 | $420 |
| Lisinopril | 62 | $391 |
| Doxycycline Hyclate | 83 | $372 |
| Metoprolol Succinate | 27 | $317 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 35 | $309 |
| Fluticasone Propionate | 57 | $305 |
| Atorvastatin Calcium | 60 | $272 |
| Amlodipine Besylate | 67 | $234 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $256 | $18,78520 claims |
| GSKTrelegy Ellipta | $28 | $12,04620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.
Other family in Scottsville
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.